Forty-three-year-old Michael walked into the George Washington University Hospital Emergency Room complaining of chest pain. The Washington D.C. handyman had no health insurance but was not eligible for any financial assistance programs.
Medical Partners
The Larry King Cardiac Foundation would like to thank St. Jude Medical for its generous donation to support our efforts. Learn more about St Jude Medical 
For 50 years, Cordis Corporation, a Johnson & Johnson Company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the needs of patients and healthcare providers have made Cordis the world's leading developer and manufacturer of breakthrough stents, catheters and guidewires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.
Cordis introduced the first Drug Eluting Stent, the CYPHER® Stent in 2003. The CYPHER® Stent can widen clogged arteries to increase the flow of blood to your heart with a shorter recovery time when compared to more invasive options. The CYPHER® Sirolimus-eluting Coronary Stent has been used by more doctors in more patients than any other drug-eluting stent. In studies conducted all over the world, its safety and effective performance continues to be proven again and again.
Cordis employees continue to share their commitment to improving lives by leading groundbreaking product development work and by providing life saving products to patients in need. Cordis is proud to participate in the fight against vascular disease with the Larry King Cardiac Foundation since it began in 1988. Learn more about Cordis
Special Thanks to Our Other Sponsors
